Status:
RECRUITING
Telerehabilitation for Aphasia (TERRA)
Lead Sponsor:
University of South Carolina
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Medical University of South Carolina
Conditions:
Aphasia
Stroke
Eligibility:
All Genders
21-80 years
Phase:
NA
Brief Summary
Speech-language therapy is generally found to be helpful in the rehabilitation of aphasia. However, not all patients with aphasia have access to adequate treatment to maximize their recovery. The goal...
Detailed Description
Stroke is the leading cause of adult disability in the United States. One of the most debilitating impairments resulting from stroke is aphasia, a language disorder caused by damage to the left hemisp...
Eligibility Criteria
Inclusion
- Participants must have sustained a left hemisphere ischemic or hemorrhagic stroke at least 12 months prior to enrollment.
- Participants must primarily speak English for at least the past 20 years.
- Participants must be capable of giving informed consent or indicating another to provide informed consent.
- Participants must be between 21-80 years of age.
- Participants must be magnetic resonance imaging (MRI) compatible (e.g., no metal implants, not claustrophobic) on a 3-Tesla (3T) scanner.
Exclusion
- Participants must not have previous neurological disease affecting the brain (e.g. history of traumatic brain injury).
- Participants must not have severely limited speech production (severe unintelligibility) and/or auditory comprehension that interferes with adequate participation in the therapy provided (i.e., WAB-R Spontaneous Speech rating scale score of 0-1 or WAB-R Comprehension score of 0-1).
- Participants must not have a history of stroke to the right hemisphere of the brain.
- Participants must not have a bilateral, cerebellar or brainstem stroke.
- Participants must not have anything that makes them be 3T MRI incompatible
- Insufficient intelligible speech to provide accurate responses with discourse/naming.
Key Trial Info
Start Date :
May 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04682223
Start Date
May 5 2021
End Date
March 31 2026
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of South Carolina Aphasia Lab
Columbia, South Carolina, United States, 29201